申请人:E. I. Du Pont de Nemours and Company
公开号:US05236934A1
公开(公告)日:1993-08-17
Provided are 1,2,3,4-tetrahydroisoquinolines, methods for preparing them, pharmaceutical compositions containing them, and methods of using them to treat disorders of mammals mediated by AT.sub.2 receptors in the central nervous system.
提供了1,2,3,4-四氢异喹啉,制备它们的方法,含有它们的药物组合物,以及使用它们治疗哺乳动物中枢神经系统AT.sub.2受体介导的疾病的方法。